Skip to content
10-K

Annual Report

ACHIEVE LIFE SCIENCES, INC. ACHV

0000950170-25-036831

← back to feed
Filed
Mar 11, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 11, 2025 34.69M sh
Sga Expense FY 2024 · Dec 31, 2024 $16.25M
Sga Expense FY 2024 · Dec 31, 2023 $11.44M
Sga Expense FY 2024 · Dec 31, 2022 $10.72M
Rd Expense FY 2024 · Dec 31, 2024 $22.82M
Rd Expense FY 2024 · Dec 31, 2023 $15.81M
Rd Expense FY 2024 · Dec 31, 2022 $30.08M
Cash And Equivalents FY 2024 · Dec 31, 2023 $15.55M
Current Liabilities FY 2024 · Dec 31, 2023 $20.81M
Total Liabilities FY 2024 · Dec 31, 2023 $20.82M
Current Assets FY 2024 · Dec 31, 2023 $16.98M
Total Assets FY 2024 · Dec 31, 2023 $19.37M
Shares Diluted FY 2024 · Dec 31, 2022 10.59M sh
Operating Cash Flow restated FY 2024 · Dec 31, 2022 −$37.57M
Eps Diluted FY 2024 · Dec 31, 2022 −$4.00
Eps Basic FY 2024 · Dec 31, 2022 −$4.00
Net Income FY 2024 · Dec 31, 2022 −$42.35M
Stockholders Equity FY 2024 · Dec 31, 2021 $28.04M